Form 4: Vaxcyte Officer Sells Shares for Tax Obligations

Vaxcyte's Chief Technical Operations Officer, Harpreet S. Dhaliwal, disposed of 1,204 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Harpreet S. Dhaliwal, Chief Technical Operations Officer of Vaxcyte, Inc. (PCVX), reported a transaction involving company common stock.
• On September 8, 2025, Dhaliwal disposed of 1,204 shares of Vaxcyte common stock.
• The shares were surrendered to the Issuer at a price of $32.41 per share to cover applicable tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Dhaliwal beneficially owns 33,670 shares of Vaxcyte common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares to cover tax obligations upon RSU vesting, which is a neutral event and does not indicate a change in the insider's sentiment about the company's future prospects.

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects an individual's compensation-related stock activity.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in the executive's investment thesis or company fundamentals.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax withholding obligations upon RSU vesting. Such transactions are common and do not typically signal a change in the company's fundamental outlook or the executive's confidence. Therefore, it provides no new information that would warrant a change in an existing investment position, leading to a 'hold' recommendation based solely on this filing.

Keywords

Vaxcyte, PCVX, Insider Transaction, Form 4, Stock Sale, Tax Withholding, RSU Vesting, Harpreet S. Dhaliwal